
Company Number
02682211
Next Accounts
Sep 2025
Shareholders
thermo fisher (heysham) limited
Group Structure
View All
Industry
Manufacture of other organic basic chemicals
+1Registered Address
3rd floor 1 ashley road, altrincham, cheshire, WA14 2DT
Website
http://alfa.comPomanda estimates the enterprise value of AVOCADO RESEARCH CHEMICALS LIMITED at £15.3m based on a Turnover of £23.6m and 0.65x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of AVOCADO RESEARCH CHEMICALS LIMITED at £9.7m based on an EBITDA of £2.2m and a 4.5x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of AVOCADO RESEARCH CHEMICALS LIMITED at £26.6m based on Net Assets of £16.6m and 1.6x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Avocado Research Chemicals Limited is a live company located in cheshire, WA14 2DT with a Companies House number of 02682211. It operates in the manufacture of other inorganic basic chemicals sector, SIC Code 20130. Founded in January 1992, it's largest shareholder is thermo fisher (heysham) limited with a 100% stake. Avocado Research Chemicals Limited is a mature, large sized company, Pomanda has estimated its turnover at £23.6m with low growth in recent years.
Pomanda's financial health check has awarded Avocado Research Chemicals Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 4 areas for improvement. Company Health Check FAQs
7 Strong
1 Regular
4 Weak
Size
annual sales of £23.6m, make it smaller than the average company (£39.9m)
£23.6m - Avocado Research Chemicals Limited
£39.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (8.6%)
1% - Avocado Research Chemicals Limited
8.6% - Industry AVG
Production
with a gross margin of 22.9%, this company has a comparable cost of product (20.1%)
22.9% - Avocado Research Chemicals Limited
20.1% - Industry AVG
Profitability
an operating margin of 6.3% make it more profitable than the average company (5.1%)
6.3% - Avocado Research Chemicals Limited
5.1% - Industry AVG
Employees
with 129 employees, this is above the industry average (81)
129 - Avocado Research Chemicals Limited
81 - Industry AVG
Pay Structure
on an average salary of £49.8k, the company has a lower pay structure (£63.4k)
£49.8k - Avocado Research Chemicals Limited
£63.4k - Industry AVG
Efficiency
resulting in sales per employee of £183.1k, this is less efficient (£493.4k)
£183.1k - Avocado Research Chemicals Limited
£493.4k - Industry AVG
Debtor Days
it gets paid by customers after 24 days, this is earlier than average (45 days)
24 days - Avocado Research Chemicals Limited
45 days - Industry AVG
Creditor Days
its suppliers are paid after 31 days, this is slower than average (27 days)
31 days - Avocado Research Chemicals Limited
27 days - Industry AVG
Stock Days
it holds stock equivalent to 216 days, this is more than average (53 days)
216 days - Avocado Research Chemicals Limited
53 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 9 weeks, this is more cash available to meet short term requirements (7 weeks)
9 weeks - Avocado Research Chemicals Limited
7 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 27.1%, this is a lower level of debt than the average (47.1%)
27.1% - Avocado Research Chemicals Limited
47.1% - Industry AVG
Avocado Research Chemicals Limited's latest turnover from December 2023 is £23.6 million and the company has net assets of £16.6 million. According to their latest financial statements, Avocado Research Chemicals Limited has 129 employees and maintains cash reserves of £1.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 23,616,000 | 25,791,000 | 24,288,000 | 22,681,000 | 22,943,000 | 23,615,000 | 24,345,000 | 17,192,000 | 20,873,000 | 20,756,000 | 20,703,000 | 19,689,000 | 19,460,000 | 20,493,000 | 17,545,000 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 18,209,000 | 20,921,000 | 20,487,000 | 18,391,000 | 17,258,000 | 17,124,000 | 18,327,000 | 17,132,000 | 14,198,000 | 14,172,000 | 13,479,000 | 12,643,000 | 13,058,000 | 14,050,000 | 11,569,000 |
Gross Profit | 5,407,000 | 4,870,000 | 3,801,000 | 4,290,000 | 5,685,000 | 6,491,000 | 6,018,000 | 60,000 | 6,675,000 | 6,584,000 | 7,224,000 | 7,046,000 | 6,402,000 | 6,443,000 | 5,976,000 |
Admin Expenses | 3,916,000 | 4,783,000 | 3,942,000 | 3,511,000 | 3,192,000 | 3,264,000 | 2,998,000 | 2,544,000 | 3,541,000 | 1,606,000 | 3,900,000 | 2,882,000 | 2,344,000 | 2,737,000 | 2,290,000 |
Operating Profit | 1,491,000 | 87,000 | -141,000 | 779,000 | 2,493,000 | 3,227,000 | 3,020,000 | -2,484,000 | 3,134,000 | 4,978,000 | 3,324,000 | 4,164,000 | 4,058,000 | 3,706,000 | 3,686,000 |
Interest Payable | 1,000 | 42,000 | 3,000 | 190,000 | 526,000 | 510,000 | 610,000 | 478,000 | 47,000 | 101,000 | |||||
Interest Receivable | 2,000 | 20,000 | |||||||||||||
Pre-Tax Profit | 1,490,000 | 45,000 | -144,000 | 781,000 | 2,513,000 | 3,227,000 | 3,016,000 | -2,484,000 | 2,733,000 | 4,452,000 | 2,814,000 | 3,554,000 | 3,580,000 | 3,659,000 | 3,585,000 |
Tax | -348,000 | -169,000 | 130,000 | 188,000 | 8,000 | 7,000 | 19,000 | 94,000 | -10,000 | -39,000 | -40,000 | -7,000 | -656,000 | -1,125,000 | -804,000 |
Profit After Tax | 1,142,000 | -124,000 | -14,000 | 969,000 | 2,521,000 | 3,234,000 | 3,035,000 | -2,390,000 | 2,723,000 | 4,413,000 | 2,774,000 | 3,547,000 | 2,924,000 | 2,534,000 | 2,781,000 |
Dividends Paid | 2,500,000 | 7,500,000 | 8,500,000 | 4,413,000 | 2,774,000 | 3,547,000 | 2,924,000 | 7,637,000 | 20,000,000 | ||||||
Retained Profit | -1,358,000 | -124,000 | -7,514,000 | 969,000 | -5,979,000 | 3,234,000 | 3,035,000 | -2,390,000 | -1,690,000 | 1,639,000 | -773,000 | 623,000 | -4,713,000 | -17,466,000 | 2,781,000 |
Employee Costs | 6,427,000 | 6,617,000 | 5,672,000 | 4,980,000 | 5,138,000 | 5,051,000 | 4,872,000 | 3,890,000 | 4,741,000 | 4,525,000 | 4,422,000 | 4,030,000 | 4,042,000 | 3,964,000 | 3,755,000 |
Number Of Employees | 129 | 140 | 125 | 128 | 126 | 124 | 122 | 130 | 136 | 136 | 127 | 124 | 124 | 121 | 125 |
EBITDA* | 2,156,000 | 803,000 | 499,000 | 1,562,000 | 3,230,000 | 3,823,000 | 3,731,000 | -1,956,000 | 3,724,000 | 5,560,000 | 3,887,000 | 4,751,000 | 4,717,000 | 4,414,000 | 4,254,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 5,245,000 | 5,079,000 | 5,366,000 | 5,704,000 | 5,847,000 | 6,030,000 | 6,242,000 | 6,216,000 | 6,937,000 | 6,801,000 | 6,621,000 | 6,825,000 | 6,668,000 | 7,126,000 | 7,633,000 |
Intangible Assets | 246,000 | 287,000 | 271,000 | 248,000 | 81,000 | 68,000 | 169,000 | 334,000 | 118,000 | 126,000 | |||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 5,491,000 | 5,366,000 | 5,637,000 | 5,952,000 | 5,928,000 | 6,098,000 | 6,411,000 | 6,550,000 | 7,055,000 | 6,927,000 | 6,621,000 | 6,825,000 | 6,668,000 | 7,126,000 | 7,633,000 |
Stock & work in progress | 10,777,000 | 11,354,000 | 9,502,000 | 9,240,000 | 9,633,000 | 9,129,000 | 9,341,000 | 9,197,000 | 13,194,000 | 13,420,000 | 13,781,000 | 13,769,000 | 13,016,000 | 12,066,000 | 12,205,000 |
Trade Debtors | 1,553,000 | 2,287,000 | 2,789,000 | 2,085,000 | 1,997,000 | 1,283,000 | 3,288,000 | 1,789,000 | 2,570,000 | 1,559,000 | 1,714,000 | 1,624,000 | 1,321,000 | 2,313,000 | 2,049,000 |
Group Debtors | 3,135,000 | 4,373,000 | 4,835,000 | 9,969,000 | 6,783,000 | 9,083,000 | 6,574,000 | 2,299,000 | 2,992,000 | 1,343,000 | 1,245,000 | 2,132,000 | 1,342,000 | 1,135,000 | |
Misc Debtors | 645,000 | 932,000 | 895,000 | 1,079,000 | 856,000 | 650,000 | 457,000 | 392,000 | 484,000 | 263,000 | 194,000 | 343,000 | 362,000 | 82,000 | |
Cash | 1,149,000 | 1,407,000 | 305,000 | 1,151,000 | 2,465,000 | 1,436,000 | 2,095,000 | 2,158,000 | 3,640,000 | 3,027,000 | 6,688,000 | 1,763,000 | 9,816,000 | 4,241,000 | 8,077,000 |
misc current assets | |||||||||||||||
total current assets | 17,259,000 | 20,353,000 | 18,326,000 | 23,524,000 | 21,734,000 | 26,446,000 | 24,457,000 | 20,175,000 | 22,095,000 | 21,482,000 | 23,789,000 | 18,595,000 | 26,628,000 | 20,324,000 | 23,548,000 |
total assets | 22,750,000 | 25,719,000 | 23,963,000 | 29,476,000 | 27,662,000 | 32,544,000 | 30,868,000 | 26,725,000 | 29,150,000 | 28,409,000 | 30,410,000 | 25,420,000 | 33,296,000 | 27,450,000 | 31,181,000 |
Bank overdraft | 205,000 | ||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 1,577,000 | 2,021,000 | 1,720,000 | 2,181,000 | 1,351,000 | 1,133,000 | 2,341,000 | 2,047,000 | 2,018,000 | 803,000 | 984,000 | 1,407,000 | 883,000 | 1,066,000 | 756,000 |
Group/Directors Accounts | 3,553,000 | 4,791,000 | 3,202,000 | 1,183,000 | 1,632,000 | 1,535,000 | 783,000 | 598,000 | 22,255,000 | 25,925,000 | 19,527,000 | 27,772,000 | 16,693,000 | 3,689,000 | |
other short term finances | 967,000 | ||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 1,040,000 | 1,167,000 | 1,384,000 | 956,000 | 588,000 | 505,000 | 546,000 | 571,000 | 879,000 | 692,000 | 922,000 | 1,701,000 | 2,013,000 | 1,324,000 | |
total current liabilities | 6,170,000 | 7,979,000 | 6,306,000 | 4,320,000 | 3,571,000 | 2,565,000 | 4,381,000 | 3,376,000 | 3,187,000 | 23,937,000 | 27,601,000 | 21,856,000 | 30,356,000 | 19,772,000 | 5,974,000 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | 43,000 | ||||||||||||||
other liabilities | |||||||||||||||
provisions | 224,000 | 19,000 | 1,000 | 25,000 | 88,000 | ||||||||||
total long term liabilities | 224,000 | 43,000 | 19,000 | 1,000 | 25,000 | 88,000 | |||||||||
total liabilities | 6,170,000 | 7,979,000 | 6,306,000 | 4,320,000 | 3,571,000 | 2,565,000 | 4,381,000 | 3,376,000 | 3,411,000 | 23,980,000 | 27,620,000 | 21,857,000 | 30,356,000 | 19,797,000 | 6,062,000 |
net assets | 16,580,000 | 17,740,000 | 17,657,000 | 25,156,000 | 24,091,000 | 29,979,000 | 26,487,000 | 23,349,000 | 25,739,000 | 4,429,000 | 2,790,000 | 3,563,000 | 2,940,000 | 7,653,000 | 25,119,000 |
total shareholders funds | 16,580,000 | 17,740,000 | 17,657,000 | 25,156,000 | 24,091,000 | 29,979,000 | 26,487,000 | 23,349,000 | 25,739,000 | 4,429,000 | 2,790,000 | 3,563,000 | 2,940,000 | 7,653,000 | 25,119,000 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 1,491,000 | 87,000 | -141,000 | 779,000 | 2,493,000 | 3,227,000 | 3,020,000 | -2,484,000 | 3,134,000 | 4,978,000 | 3,324,000 | 4,164,000 | 4,058,000 | 3,706,000 | 3,686,000 |
Depreciation | 601,000 | 659,000 | 640,000 | 640,000 | 617,000 | 596,000 | 546,000 | 408,000 | 510,000 | 582,000 | 563,000 | 587,000 | 659,000 | 708,000 | 568,000 |
Amortisation | 64,000 | 57,000 | 143,000 | 120,000 | 165,000 | 120,000 | 80,000 | ||||||||
Tax | -348,000 | -169,000 | 130,000 | 188,000 | 8,000 | 7,000 | 19,000 | 94,000 | -10,000 | -39,000 | -40,000 | -7,000 | -656,000 | -1,125,000 | -804,000 |
Stock | -577,000 | 1,852,000 | 262,000 | -393,000 | 504,000 | -212,000 | 144,000 | -4,223,000 | -226,000 | -361,000 | 12,000 | 753,000 | 950,000 | -139,000 | 12,205,000 |
Debtors | -2,259,000 | -927,000 | -4,614,000 | 3,497,000 | 8,353,000 | -11,738,000 | 4,201,000 | 3,785,000 | 226,000 | 1,715,000 | 257,000 | -733,000 | -221,000 | 751,000 | 3,266,000 |
Creditors | -444,000 | 301,000 | -461,000 | 830,000 | 218,000 | -1,208,000 | 294,000 | 1,244,000 | 1,215,000 | -181,000 | -423,000 | 524,000 | -183,000 | 310,000 | 756,000 |
Accruals and Deferred Income | -127,000 | -217,000 | 428,000 | 368,000 | 588,000 | -505,000 | -41,000 | -376,000 | -351,000 | 230,000 | -230,000 | -779,000 | -312,000 | 689,000 | 1,324,000 |
Deferred Taxes & Provisions | 224,000 | -19,000 | 18,000 | 1,000 | -25,000 | -63,000 | 88,000 | ||||||||
Cash flow from operations | 4,073,000 | -207,000 | 4,948,000 | -156,000 | -4,813,000 | -342,000 | -556,000 | 4,802,000 | 4,197,000 | 2,943,000 | 4,470,000 | 2,812,000 | 3,613,000 | -9,853,000 | |
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -1,238,000 | 1,589,000 | 2,019,000 | -449,000 | 1,632,000 | -1,535,000 | 752,000 | -21,472,000 | -21,657,000 | -3,670,000 | 6,398,000 | -8,245,000 | 11,079,000 | 13,004,000 | 3,689,000 |
Other Short Term Loans | -967,000 | 967,000 | |||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | -1,000 | -42,000 | -3,000 | 2,000 | 20,000 | -190,000 | -526,000 | -510,000 | -610,000 | -478,000 | -47,000 | -101,000 | |||
cash flow from financing | -1,041,000 | 1,754,000 | 2,031,000 | -351,000 | 776,000 | 855,000 | -162,000 | 1,153,000 | -4,196,000 | 5,888,000 | -8,855,000 | 10,601,000 | 12,957,000 | 25,926,000 | |
cash and cash equivalents | |||||||||||||||
cash | -258,000 | 1,102,000 | -846,000 | -1,314,000 | 1,029,000 | -659,000 | -63,000 | -869,000 | 613,000 | -3,661,000 | 4,925,000 | -8,053,000 | 5,575,000 | -3,836,000 | 8,077,000 |
overdraft | -205,000 | 205,000 | |||||||||||||
change in cash | -258,000 | 1,102,000 | -846,000 | -1,314,000 | 1,029,000 | -659,000 | -63,000 | -869,000 | 613,000 | -3,661,000 | 4,925,000 | -8,053,000 | 5,575,000 | -3,631,000 | 7,872,000 |
Perform a competitor analysis for avocado research chemicals limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in WA14 area or any other competitors across 12 key performance metrics.
AVOCADO RESEARCH CHEMICALS LIMITED group structure
Avocado Research Chemicals Limited has no subsidiary companies.
Ultimate parent company
THERMO FISHER SCIENTIFIC INC
#0013877
2 parents
AVOCADO RESEARCH CHEMICALS LIMITED
02682211
Avocado Research Chemicals Limited currently has 5 directors. The longest serving directors include Mr Euan Cameron (Oct 2018) and Mr Anthony Smith (Nov 2018).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Euan Cameron | United Kingdom | 49 years | Oct 2018 | - | Director |
Mr Anthony Smith | United Kingdom | 63 years | Nov 2018 | - | Director |
Mr Syed Ahmed | United Kingdom | 45 years | Mar 2020 | - | Director |
Ms Alison Starr | 48 years | Apr 2024 | - | Director | |
Ms Georgina Green | United Kingdom | 55 years | Apr 2024 | - | Director |
P&L
December 2023turnover
23.6m
-8%
operating profit
1.5m
+1614%
gross margin
22.9%
+21.25%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
16.6m
-0.07%
total assets
22.8m
-0.12%
cash
1.1m
-0.18%
net assets
Total assets minus all liabilities
company number
02682211
Type
Private limited with Share Capital
industry
20140 - Manufacture of other organic basic chemicals
20130 - Manufacture of other inorganic basic chemicals
incorporation date
January 1992
age
33
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
MITCHELL CHARLESWORTH (AUDIT) LIMITED
address
3rd floor 1 ashley road, altrincham, cheshire, WA14 2DT
Bank
BARCLAYS BANK PLC
Legal Advisor
ADDLESHAW GODDARD
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to avocado research chemicals limited. Currently there are 0 open charges and 3 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AVOCADO RESEARCH CHEMICALS LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|